News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
Opinion|Videos|December 15, 2023

Diagnosing Myelofibrosis

Author(s)Christine Cooper, RN, BSN, Aaron Gerds, MD, MS

Patients with myelofibrosis commonly present with fatigue, weight loss, night sweats, bone pain, low blood counts, and concentration issues, with diagnosis requiring bone marrow biopsy.

Advertisement

Episodes in this series

EP. 1 Diagnosing Myelofibrosis
Now Playing
EP. 1 Diagnosing Myelofibrosis
EP. 2 Assessing Risk Level of Patients With Myelofibrosis
EP. 2 Assessing Risk Level of Patients With Myelofibrosis
EP. 3 Educational Resources for Patients Diagnosed With Myelofibrosis
EP. 3 Educational Resources for Patients Diagnosed With Myelofibrosis
EP. 4 Key Patient Goals for Myelofibrosis Management
EP. 4 Key Patient Goals for Myelofibrosis Management
EP. 5 Management of Anemia in Patients With Myelofibrosis
EP. 5 Management of Anemia in Patients With Myelofibrosis
EP. 6 Clinical Data on the Approved JAK Inhibitors for Treatment of Myelofibrosis
EP. 6 Clinical Data on the Approved JAK Inhibitors for Treatment of Myelofibrosis
EP. 7 Adverse Events Seen With JAK Inhibitors for Myelofibrosis
EP. 7 Adverse Events Seen With JAK Inhibitors for Myelofibrosis
EP. 8 Assessing Treatment Response in Patients With Myelofibrosis
EP. 8 Assessing Treatment Response in Patients With Myelofibrosis
EP. 9 Best Approaches to Switching Therapies for a Patient With Myelofibrosis
EP. 9 Best Approaches to Switching Therapies for a Patient With Myelofibrosis
EP. 10 Dosing JAK Inhibitors in Patients With Myelofibrosis
EP. 10 Dosing JAK Inhibitors in Patients With Myelofibrosis
EP. 11 Key Takeaways for Patients With Myelofibrosis
EP. 11 Key Takeaways for Patients With Myelofibrosis

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement
Advertisement
Advertisement

Trending on CURE

1

Trodelvy Improves Survival in EGFR-Mutated Non-Small Cell Lung Cancer

2

Imfinzi Combo Improves Progression Free Survival in Ovarian Cancer

3

Imfinzi With Chemo Produces Inconclusive Outcomes in Phase 3 Mesothelioma Study

4

Trodelvy in Metastatic Triple-Negative Breast Cancer Supported by Phase 3 Trial

5

Ivonescimab Combo Improves Progression-Free Survival in Advanced NSCLC

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.